Get 25% discount on our yearly plans! Subscribe now

Key Metrics
Market Cap
Total Shares Outstanding
Book Value
PE Ratio
PS Ratio
PB Ratio
Forward PE Ratio
ROIC
Return on Aseets
Return on Equity
Dividend
Dividend Yield
Balancesheet Metrics
Total Assets 10.35M
Total Liability 11.13M
Assets-to-Libability Ratio 0.93
Total Current Assets 4.12M
Total Current Liability 10.04M
Current Ratio 0.41
Quick Ratio 0.36
Debt to Equity Ratio -5.25
Income Statement Metrics
Net Income
EPS
EBITA
Gross Profit
Gross Profit Margin
Operating Margin
Net Profit Margin
Price Metrics
5 Days MA
10 Days MA
20 Days MA
50 Days MA
200 Days MA
52 Weeks High
52 Weeks low
All Time High
RSI
MACD
Share Stats
Shares Float
Shares Short
% Short
% Insider
% Institutions
News

Profile

Ricebran Tech (RIBT)

RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company in the United States and internationally. It focuses on development, production, and marketing of products derived from rice and other small and ancient grains for the nutraceutical, healthy food, companion animal, and equine feed categories. The company converts raw rice bran into stabilized rice bran (SRB) and high value SRB derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious, carbohydrate, and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and ProRyza products, which includes derivatives composed of protein and protein/fiber blends. It serves food and animal nutrition manufacturers, wholesalers, and retailers. The company was formerly known as NutraCea and changed its name to RiceBran Technologies in October 2012. RiceBran Technologies was founded in 2000 and is headquartered in Tomball, Texas.

Exchange: NASDAQ

IPO Date: 9/18/1998

Sector: Consumer Defensive

Industry: Packaged Foods

Employees: 94

Address: 25420 Kuykendahl Road, Tomball, TX, United States, 77375

https://www.ricebrantech.com

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;09/30/202306/30/202303/31/202312/31/202209/30/202206/30/202203/31/202212/31/202109/30/202106/30/2021Totals
Assets
10.35K11.37K26.55K27.43K30.11K29.92K31.34K31.31334.74K32.66K1.24M
Current Assets
4.12K4.80K10.30K11.07K13.20K12.70K13.93K13.21512.36K10.25K433.54K
Cash And Short Term Investments
4663023.41K3.94K4.37K5.12K5.87K5.8256.19K4.01K189.62K
Net Receivables
2.62K3.37K3.34K3.70K5.00K4.04K4.63K4.1362.83K2.56K119.20K
Inventory
5144662.56K2.38K2.69K2.31K2.48K2.4442.17K1.84K85.88K
Other Current Assets
5156679891.05K1.15K1.23K9520.811.18K1.84K47.45K
Non Current Assets
6.23K6.56K16.25K16.36K16.91K17.22K17.41K18.09822.38K22.41K807.70K
Property Plant Equipment
----16.50K16.77K16.93K17.57K17.89K17.88K611.45K
Long Term Investments
----------3.44K
Non Currrent Assets Other
--14.207-14.62914.81514.887-15.68-39.03K
Liabilities
11.13K10.48K15.35K14.52K16.91K15.17K14.12K12.81811.13K9.85K672.86K
Current Liabilities
10.04K9.46K12.16K11.28K14.34K11.80K10.78K9.1568.30K7.58K437.71K
Accounts Payable
1.41K1.44K1.87K1.23K1.45K1.37K1.67K0.826911796194.40K
Short Long Term Debt
3.38K3.38K5.86K5.98K8.11K6.22K4.66K4.56K3.45K3.40K103.26K
Other Current Liabilities
7.22K6.55K3.91K3.37K4.24K3.72K3.97K6.6793.48K2.94K154.59K
Non Current Liabilities
1.09K1.03K3.18K3.25K2.57K3.37K3.34K3.6622.83K2.27K235.15K
Long Term Debt
-----708----137.15K
Other Liabilities
----234846429258647-26.92K
Stockholder Equity
-78488211.21K12.91K13.20K14.75K17.23K18.49523.61K22.81K577.39K
Preferred Stock Equity
-----75---1128.62K
Liabilities And Stockholders Equity
10.35K11.37K26.55K27.43K30.11K29.92K31.34K31.31334.74K32.66K1.24M
Common Equity
-----326.67K---322.94K8.86M
Retained Earnings
------312.00K----300.24K-8.31M
Totals68.64K72.12K143.50K145.90K181.10K191.94K181.10K22.55K188.84K198.56K212.79K207.09K210.07K215.33K241.00K241.22K214.06K246.51K205.04K188.62K140.48K119.35K101.96K106.79K223.40K224.69K232.40K207.63K232.77K224.93K235.45K235.59K241.91K268.82K257.76K299.69K297.32K344.00K339.64K7.91M
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;12/31/202212/31/202112/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/2014Totals
Assets
27.43K31.31K34.80K40.49K30.72K17.36K28.84K33.63K46.08K290.68K
Current Assets
11.07K13.21K11.34K13.77K12.51K9.45K7.53K10.72K14.07K103.68K
Cash And Short Term Investments
3.94K5.83K5.26K8.44K7.04K6.20K4512.99K5.53K45.69K
Net Receivables
3.70K4.14K2.82K3.74K3.68K1.27K2.09K2.98K3.79K28.21K
Inventory
2.38K2.44K1.88K8989586783.77K3.86K3.51K20.37K
Other Current Assets
1.05K8101.38K6918351.29K1.21K8951.07K9.23K
Non Current Assets
16.36K18.10K23.46K26.72K18.20K7.91K21.32K22.91K32.01K187.00K
Property Plant Equipment
-17.57K16.37K19.08K15.01K7.85K18.93K18.33K24.75K137.89K
Long Term Investments
------1.24K--1.24K
Non Currrent Assets Other
14.20715.444-2716631.35K103881.68K
Liabilities
14.52K12.82K11.38K8.75K7.01K2.63K28.93K26.37K30.41K142.81K
Current Liabilities
11.28K9.16K5.83K5.81K6.86K2.62K21.36K14.68K15.13K92.72K
Accounts Payable
1.23K8269558334.32K76511.48K9.63K9.75K39.79K
Short Long Term Debt
5.98K4.56K2.36K1.85K68649.88K5.05K4.81K35.17K
Other Current Liabilities
3.37K3.17K2.09K2.71K1.71K1.77K16.18K7.11K57338.69K
Non Current Liabilities
3.25K3.66K5.55K2.94K145127.57K11.69K15.28K50.09K
Long Term Debt
---73145126.01K10.91K11.29K28.43K
Other Liabilities
-258----1.60K7129553.52K
Stockholder Equity
12.91K18.50K23.42K31.74K23.71K14.73K-6327.27K15.67K147.32K
Preferred Stock Equity
--112112201313551--1.29K
Liabilities And Stockholders Equity
27.43K31.31K34.80K40.49K30.72K17.36K28.84K33.63K46.08K290.68K
Common Equity
--322.22K318.81K296.74K279.55K264.23K262.89K261.30K2.01M
Retained Earnings
---298.91K-287.18K-273.23K-265.13K-259.82K-250.74K-242.47K-1.88M
Totals145.91K177.69K207.09K240.80K187.99K106.72K222.93K235.63K299.69K1.82M
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;06/30/202203/31/202212/31/202109/30/202106/30/202103/31/202112/31/202009/30/202006/30/202003/31/2020Totals
Revenue
10.19K10.56K-6.44K6.91K7.57K8.61K6.81K5.16K5.90K8.33K240.84K
Cost Of Revenue
10.67K10.06K8.15K7.18K7.42K7.93K6.85K5.96K7.13K8.73K229.32K
Gross Profit
-477502-14.59K-276153672-47-795-1.22K-40511.52K
Operating Expenses
12.38K1.69K1.61K1.80K1.93K1.74K9311.88K2.62K2.55K112.07K
Selling General Administrative
1.71K1.69K1.61K1.80K1.93K1.74K9311.88K2.62K2.55K95.36K
Research Development
-----------
Other Operating Expenses
-11.75K9.76K8.99K9.35K9.67K7.78K7.83K9.74K11.29K318.34K
Operating Income
-2.19K-1.19K-5.63K-2.08K-1.78K-1.08K-978-2.67K-3.84K-2.96K-79.32K
Net Interest Income
-117-125-110-121-120-111-122-70-68-38-1.05K
Interest Income
11---11-81161
Interest Expense
118126-81612112011212370764919.53K
Other Income Expense Net
-307-326250-136-1441.67K-985-961107831.47K
Income Before Tax
-2.61K-1.52K-5.38K-2.21K-1.92K592-1.96K-2.77K-3.95K-3.03K-110.80K
Tax Provision
12-20--1118--52
NetIncome
-2.62K-1.52K-5.40K-2.21K-1.92K591-1.97K-2.77K-3.95K-3.03K-90.40K
NetIncome Applicable To Common Shares
-2.62K-1.52K-5.40K-2.21K-1.92K591-1.97K-2.77K-3.95K-3.03K-92.56K
Ebit
-2.19K-1.39K-1.72K-2.09K-1.80K704-1.84K-2.70K-3.84K-2.96K-74.18K
Basic EPS
--0.03-0.03-0.05-0.040.01-0.05-0.07-0.1-0.08-8.659999999999998
Totals21.95K28.80K-24.10K15.46K18.87K33.44K13.56K8.13K7.38K18.14K8.83K8.57K10.90K9.36K10.33K8.64K6.60K8.74K-388.0619.92K9.67K35.28K34.67K28.56K22.84K35.42K32.74K31.73K30.97K26.10K29.80K27.07K7.95K24.31K610.25K
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;12/31/202112/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/2014Totals
Revenue
31.13K26.20K23.71K14.76K13.36K39.41K39.90K40.11K228.57K
Cost Of Revenue
30.69K28.67K24.57K11.78K9.56K31.44K31.83K35.64K204.18K
Gross Profit
442-2.47K-8612.98K3.79K7.97K8.07K4.47K24.39K
Operating Expenses
7.09K7.97K13.70K11.19K9.89K16.08K14.35K17.23K97.49K
Selling General Administrative
7.09K7.97K13.70K11.19K9.89K14.81K12.57K14.35K91.56K
Research Development
---------
Other Operating Expenses
37.78K36.64K38.27K22.97K19.45K47.51K46.17K52.87K301.67K
Operating Income
-10.57K-11.29K-14.56K-8.21K-6.10K-8.11K-6.28K-12.76K-77.87K
Net Interest Income
-462-298-46-12-1.62K-3.93K---6.37K
Interest Income
12050-12-953100-2.36K--3.16K
Interest Expense
-46331896121.62K4.03K3.10K10.33K19.05K
Other Income Expense Net
1.64K-422822156-9.12K3.10K4.48K15.17K15.82K
Income Before Tax
-8.93K-11.71K-13.73K-8.06K-15.21K-11.21K-10.75K-27.93K-107.54K
Tax Provision
2119-45-5.03K41-176--5.08K
NetIncome
-8.95K-11.73K-13.95K-8.10K-4.53K-8.53K-8.27K-23.03K-87.09K
NetIncome Applicable To Common Shares
-8.95K-11.73K-13.95K-8.10K-5.31K-9.08K-8.27K-23.03K-88.42K
Ebit
-6.64K-11.39K-13.86K-8.04K-7.94K-4.46K-5.34K-14.00K-71.67K
Basic EPS
-0.11-0.3-0.41-0.38-0.94-0.98-40.97-40.07-84.16
Totals70.91K46.76K43.96K34.56K11.75K119.16K118.97K89.38K535.46K
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;09/30/202306/30/202303/31/202312/31/202209/30/202206/30/202203/31/202212/31/202109/30/202106/30/2021Totals
Cash From Operating Activities
563-1.49K-62-77-2.12K-1.93K190-2.21K-569-1.42K-51.94K
Net Income
-1.78K-1.32K-2.03K-1.68K-2.04K-2.62K-1.52K-5.40K-2.21K-1.92K-99.25K
Depreciation
257-2454655956456855962165065625.17K
Extraordinary Items
-----------
Change Receivables
---------1.07K-166
Change To Inventory
-48183-184309-375171-39-271-337-342-1.65K
Change To Liabilities
----447-237884-314397-3113.64K
Change To Net Income
-----985513693.78K34333415.88K
ChangeToOperatingActivities
----327-833426688871-899-743
Cash flows From Investing Activities
----10-264-48-249-27248-6.45K
Capital Expenditures
-294-87-230-152-10-264-157-253-647-215-19.06K
Other Cashflows From Investing Activities
------109137526311.05K
Cash From Financing Activities
-105-3.21K-237-2041.36K1.45K-992.10K3.02K-4145.53K
Net Borrowings
----1.36K1.45K-992.11K-353-212-10.10K
Sale Purchase Of Stock
--------8-17125.04K
Dividends Paid
-----------
Other Cashflows From Financing Activities
-7.50K11.11K10.95K11.62K11.36K9.01K-9.50K8.93K238.45K
Cash And Cash Equivalents Changes
----------1.41K-497
Totals-1.41K1.55K8.91K9.71K11.04K9.40K9.59K58510.77K4.71K8.81K11.54K7.70K1.47K23214.06K-10.49K-17.12K-2.21K-10.16K13.24K9.53K-4.42K-8.07K26.66K-1.57K20.46K4.08K10.75K7.28K15.91K5.18K6.44K9.93K-2.90K7.54K-12.04K-4.20K2.41K174.90K
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;12/31/202312/31/202212/31/202112/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/2014Totals
Cash From Operating Activities
-1.16K-3.94K-4.20K-7.95K-13.45K-5.24K-3.77K-3.93K-3.79K-10.07K-57.49K
Net Income
-15.82K-7.86K-8.95K-11.73K-13.73K-8.10K-4.53K-8.53K-8.27K-23.03K-110.55K
Depreciation
2.24K2.25K2.59K2.62K1.93K7737573.04K4.06K6.55K26.81K
Extraordinary Items
-----------
Change Receivables
---997-1.10K331-17922863-766-428
Change To Inventory
-8966-566-980332-138279248-677-138-1.66K
Change To Liabilities
--280-713-1.64K1.11K-6792.45K1.39K-2151.99K
Change To Net Income
--2.90K1.09K1.84K8724.93K1.22K9711.23K15.05K
ChangeToOperatingActivities
--876-80-1.57K87303-467-38340-1.20K
Cash flows From Investing Activities
---798-919-8.00K-5.58K15.14K1.21K-1.07K-6.13K-6.15K
Capital Expenditures
-680-563-1.44K-1.18K-4.22K-3.25K-862-720-1.07K-5.42K-19.41K
Other Cashflows From Investing Activities
--639265-4.25K-2.34K16.00K1.93K-356-70211.18K
Cash From Financing Activities
-3.69K2.51K5.56K5.68K23.10K11.12K-4.88K2.00K2.17K15.07K58.63K
Net Borrowings
--2.02K3.35K1.45K-16-15.96K-2.55K2.17K-3.27K-12.81K
Sale Purchase Of Stock
---122.23K11.11K8.30K2.04K-5.50K29.18K
Dividends Paid
-----------
Other Cashflows From Financing Activities
-42.94K32.38K33.55K9.21K11.13K12.08K40.16K25.99K20.75K228.20K
Cash And Cash Equivalents Changes
----3.18K1.65K2916.64K-619-2.54K-1.48K756
Totals-19.19K35.41K31.30K20.84K-6.22K12.15K33.55K37.69K18.66K-2.08K162.11K